For the Inventor, By the Inventor

Enter inventor name

Herzliya, Israel

Anat Shirvan

USPTO Granted Patents = 14 (Patent Applications = 3)

EPO Patents = 3 (Patent Applications = 3)

Average Co-Inventor Count = 2.2

ph-index = 3

Forward Citations = 13(Granted Patents)

Location History:

Herzilya, IL (2003)
Herzlia, IL (2007)
Herzelia, IL (2009)
Herzliya, IL (2005 - 2017)
Kfar-Saba, IL (2018 - 2019)

Company Filing History:

Nst Neurosurvival Technologies Ltd

4. 2 out of 894

Yissum Research Development Company of the Hebrew University of Jerusalem Ltd.

Nss T Neurosurvival Technologies Ltd.

where one patent can have more than one assignee

Years Active: 2003-2019

Loading Chart...

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10280209 - Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28 (2019-05-07),

2. 9963497 - Reduction of inflammatory disease symptoms by short peptides that inhibit signaling through CD28 (2018-05-08),

3. 9567367 - Synthetic peptides for treatment of bacterial infections (2017-02-14),

4. 8101666 - Methods and compounds for detection of medical disorders (2012-01-24),

5. 7947253 - Perturbed membrane-binding compounds and methods of using the same (2011-05-24),

6. 7670590 - Perturbed membrane-binding compounds and methods of using the same (2010-03-02),

7. 7605182 - Compounds that selectively bind to membranes of apoptotic cells (2009-10-20),

8. 7510825 - Kits and methods for detection of apoptotic cells (2009-03-31),

9. 7378079 - Agents for imaging and diagnostic methods using them (2008-05-27),

10. 7365223 - Method for selective targeting of apoptotic cells and small molecule ligands used thereof (2008-04-29),

11. 7270799 - Perturbed membrane-binding compounds and methods of using the same (2007-09-18),

12. 7196063 - Peptides and pharmaceutical compositions comprising same (2007-03-27),

13. 6849603 - Peptides for inhibition of apoptosis and pharmaceutical compositions containing them (2005-02-01),

14. 6602852 - Basic peptides and pharmaceutical compositions containing same (2003-08-05),

Title: Anat Shirvan: Innovator in Inflammatory Disease Treatment

Introduction

Anat Shirvan is a prominent inventor based in Herzliya, Israel. She has made significant contributions to the field of medical science, particularly in the treatment of inflammatory diseases. With a total of 14 patents to her name, her work has the potential to impact many lives.

Latest Patents

Anat Shirvan's latest patents focus on the reduction of inflammatory disease symptoms through the use of short peptides that inhibit signaling through CD28. The present disclosure relates to a method for treating non-pathogen associated inflammatory disorders in subjects in need. This involves administering an isolated peptide that specifically binds to an amino acid sequence within the dimer interface of T cell costimulatory pathway members, particularly CD28 and CTLA4. Additionally, the patents include pharmaceutical compositions comprising the isolated peptide and its use in treating non-pathogen associated inflammatory disorders.

Career Highlights

Throughout her career, Anat has worked with notable companies such as Nst Neurosurvival Technologies Ltd and Aposense Ltd. Her innovative approaches and research have positioned her as a leader in her field.

Collaborations

Anat has collaborated with esteemed colleagues, including Ilan Ziv and Raymond Kaempfer, further enhancing her research and development efforts.

Conclusion

Anat Shirvan's work in the field of inflammatory disease treatment showcases her dedication to innovation and improving patient outcomes. Her contributions through her patents and collaborations highlight her role as a significant figure in medical research.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…